Soleno Therapeutics Inc

Soleno Therapeutics, Inc. voluntarily withdrew the marketing authorization application for VIOKAT prolonged-release tablets. The decision was based on business considerations, allowing the company to re-engage with regulators later.

Soleno Therapeutics Inc SLNO is headquartered in Redwood City, CA.

Source